The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Radenska-Lopovok S.G.

FGBU "Nauchno-issledovatel'skiĭ institut revmatologii im. V.A. Nasonovoĭ" RAMN, Moskva

Kotenko O.N.

Moscow City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia

Frolova N.F.

Moscow City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia

Zagrebneva A.I.

Moscow City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia

Stolyarevich E.S.

Moscow City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia

Volodina E.V.

G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Moscow, Russia

Chervinko V.I.

Branch, S.M. Kirov Military Medical Academy, Ministry of Defense of the Russian Federation, Moscow, Russia

Krukov E.V.

Main Military Clinical Hospital named after N.N. Burdenko, Moscow, Russia

Zubkin M.L.

Moscow City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia;
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Moscow, Russia;
Branch, S.M. Kirov Military Medical Academy, Ministry of Defense of the Russian Federation, Moscow, Russia

A rare concurrence of polymyalgia rheumatica and AA-amyloidosis

Authors:

Radenska-Lopovok S.G., Kotenko O.N., Frolova N.F., Zagrebneva A.I., Stolyarevich E.S., Volodina E.V., Chervinko V.I., Krukov E.V., Zubkin M.L.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2017;79(2): 53‑57

DOI: 10.17116/patol201779253-57

Read: 6448 times

Download PDF (RU)
Contact the author
Table of contents

A RARE CONCURRENCE OF POLYMYALGIA RHEUMATICA AND AA-AMYLOIDOSIS
A RARE CONCURRENCE OF POLYMYALGIA RHEUMATICA AND AA-AMYLOIDOSIS

To cite this article:

Radenska-Lopovok SG, Kotenko ON, Frolova NF, et al. . A rare concurrence of polymyalgia rheumatica and AA-amyloidosis. Russian Journal of Archive of Pathology. 2017;79(2):53‑57. (In Russ.)
https://doi.org/10.17116/patol201779253-57

 
Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Polymyalgia rheumatica (PMR) is a rare chronic inflammatory disease. It predominantly affects the elderly. The disease has a slow onset, pain and stiffness in the muscles of the shoulder and pelvic girdle, fever, weight loss, and a high acute-phase inflammatory response. The disease is concurrent with giant cell arteritis in a quarter of cases, which allows some authors to consider them as two different manifestations of the same pathological process. The kidneys are rarely involved. This disease is rarely complicated by AA amyloidosis. The authors describe a case of RPM in a patient who has developed secondary AA amyloidosis.

Keywords:

polymyalgia rheumatica
giant cell arteritis
AA amyloidosis

Authors:

Radenska-Lopovok S.G.

FGBU "Nauchno-issledovatel'skiĭ institut revmatologii im. V.A. Nasonovoĭ" RAMN, Moskva

Kotenko O.N.

Moscow City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia

Frolova N.F.

Moscow City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia

Zagrebneva A.I.

Moscow City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia

Stolyarevich E.S.

Moscow City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia

Volodina E.V.

G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Moscow, Russia

Chervinko V.I.

Branch, S.M. Kirov Military Medical Academy, Ministry of Defense of the Russian Federation, Moscow, Russia

Krukov E.V.

Main Military Clinical Hospital named after N.N. Burdenko, Moscow, Russia

Zubkin M.L.

Moscow City Clinical Hospital Fifty-Two, Moscow Healthcare Department, Moscow, Russia;
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Moscow, Russia;
Branch, S.M. Kirov Military Medical Academy, Ministry of Defense of the Russian Federation, Moscow, Russia

Close metadata

References:

  1. Bruse W. Senile rheumatic gout. Br Med J. 1888;2(1450):811-813.
  2. Barber HS. Myalgic syndrome with constitutional effects: polymyalgia rheumatica. Ann Rheum Dis. 1957;16:230-237.
  3. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61(10):1454-1461. doi:10.1002/art.24459
  4. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al; for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58:26-35. doi:10.1002/art.23176
  5. Liozon E, Ouattara B, Rhaiem K, Ly K., Bezanahary H., Loustaud V, et al. Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families. Clin Exp Rheumatol. 2009;27(1,Suppl.52):S89-S94.
  6. Gonzalez-GayMA, AmoliMM, Garcia-PorruaC, Ollier WER. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum. 2003;33(1):38-48. doi:10.1053/sarh.2002.50025
  7. Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, et al. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol. 2006;33(4):703-708.
  8. Alvarez-Rodriguez L, Carrasco-Marin E, Lopez-Hoyos M, Mata C, Fernandez-Prieto L, Ruiz-SotoM-R, et al. Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: Association of IL-1RN*2/2 genotype with polymyalgia rheumatica. Hum Immunol. 2009;70(1):49-54.
  9. Gonzalez-Gay MA. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum. 2004;33(5):289-293.
  10. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med. 1995;123(3):192-194.
  11. Salvarani C, Cantini F, Boiardi L. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347(4):261-271. doi:10.1056/NEJMra011913
  12. Franzen P, Sutinen S, von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984—1988. J Rheumatol. 1992;19(2):273-276
  13. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med. 2003;139(6):505-515.
  14. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med. 1994;121(7):484-491.
  15. Weyand CM, Ma-Krupa W, Goronzy JJ. Immunopath ways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev. 2004;3(1):46-53. doi:10.1016/S1568-9972(03)00064-8
  16. Gonzalez-Gay MA, Hajeer AH, Dababneh A, Garcia-Porrua C, Amoli MM, Llorca J, Ollier WER. Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica. Clin Exp Rheumatol. 2004;22(6,Suppl.36):S18-S20.
  17. Meliconi R, Pulsatelli L, Uguccioni M, Salvarani C, Macchioni P, Melchiorri C, et al. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum. 1996;39(7):1199-1207.
  18. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute phase reactant. Eur J Biochem. 1999;265(2):501-523. doi:10.1046/j.1432-1327.1999.00657.x
  19. Legault K, ShroffA, Crowther M, Khalidi N. Amyloidosis and giant cell arteritis/polymyalgia rheumatic. J Rheumatol. 2012;39(4):878-880. doi:10.3899/jrheum.111013
  20. Casado E, Holgado S, Teixido J, Olive A. Giant cell (temporal) arteritis and secondary amyloid: A matter of disease duration? J Rheumatol. 1998;25(4):822.
  21. Gertz MA, Kyle RA. Secondary systemic amyloidosis: Responseand survival in 64 patients. Medicine. 1991;70(1):246-256.
  22. Javaid MM, Kamalanathan M, Kon SPh. Rapid development of renal failure secondary to AA-type amyloidosis in a patient with polymyalgia rheumatic. J Renal Care. 2010;36(4):199-202. doi:10.1111/j.1755-6686.2010.00200.x
  23. Stebbing J, Buetens O, Hellmann D, Stone J. Secondary amyloidosis associated with giant cell arteritis/polymyalgia rheumatica. J Rheumatol. 1999;26(12):2698-2700.
  24. Escriba A, Morales E, Albizua E, Herrero JC, Ortuno T, Carreno A, et al. Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica. Am J Kidney Dis. 2000;35(1):137-140. doi:10.1016/S0272-6386(00)70312-X
  25. Monteagudo M, Vidal G, Andreu J, Oristrell J, Tolosa C, Larrosa M, et al. Giant cell (temporal) arteritis and secondary renal amyloidosis: Report of 2 cases. J Rheumatol. 1997;24(3):605-607.
  26. Strasser F, Hailemariam S, Weinreich T, Speich R, Salomon F. Giant cell arteritis «causing» AA-amyloidosis with rapid renal failure. Schweiz Med Wschr. 2000;130:1606-1609.
  27. Obici L, Raimondi S, Lavatelli F, Bellotti V, Merlini G. Susceptibility to AA-amyloidosis in rheumatic diseases: a critical overview. Arthritis Rheum. 2009;61(10):1435-1440. doi:10.1002/art.24735
  28. Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356(23):2361-2371. doi:10.1056/NEJMoa070265
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.